Ptc therapeutics, inc. (PTCT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-112,687

-77,677

-59,997

-41,789

-72,113

-48,330

-50,969

-9,519

-19,263

1,270

-33,738

-17,475

-29,057

-26,796

-35,167

-38,914

-41,233

-50,948

-43,223

-38,361

-37,915

-27,269

-27,282

-25,104

-14,098

-17,886

-4,416

-14,587

-14,684

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

9,235

9,277

8,143

7,701

7,059

6,771

7,073

6,221

6,022

5,939

10,295

836

612

813

813

815

849

797

760

685

634

542

543

562

588

585

588

597

625

Non-cash lease expense

1,330

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in valuation of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-91

-3

94

-47

12

-80

-113

41

52

40

-17

55

-41

37

20

-54

Change in valuation of deferred and contingent consideration

900

12,400

9,500

5,300

21,160

19,340

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on equity investment in Clearpoint

-1,574

-335

2,400

129

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on Clearpoint convertible debt security

2,799

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

5,459

5,444

2,528

2,073

1,982

1,955

1,919

1,864

1,780

1,756

1,725

1,674

1,600

1,578

1,546

1,495

1,446

-

-

-

-

-

-

-

-

0

4

21

6,023

Amortization of discounts on investments, net

333

548

467

650

257

79

124

134

96

-42

-128

-157

-208

-275

-470

-509

-631

-1,161

-404

-429

-486

-382

-315

-496

-414

-

-

-

-

Amortization of debt issuance costs

256

260

154

141

139

134

134

130

126

125

123

105

80

78

77

75

72

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation expense

15,220

11,466

10,484

10,921

9,263

8,479

8,942

8,083

7,748

6,477

7,168

7,885

9,029

8,399

8,959

8,736

8,915

7,849

8,054

8,328

9,748

6,705

4,622

4,278

3,705

3,284

2,640

1,881

621

Unrealized foreign currency transaction losses, net

-8,675

11,824

-143

803

-865

-918

213

-536

1,300

95

2,012

-828

-820

199

-438

-963

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Inventory

-102

1,882

722

518

334

2,571

-141

1,947

1,446

2,829

819

1,456

1,350

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

6,675

-2,936

4,521

7,059

191

308

1,555

704

-958

1,214

154

509

-93

-76

68

-461

-702

1,359

392

-1,875

2,231

1,054

234

640

358

-527

527

735

25

Trade receivables, net

-2,346

-5,646

-15,581

30,488

-20,786

26,908

-17,748

16,206

4,223

1,209

4,232

16

6,746

-1,193

7,555

-2,198

10,678

3,325

2,913

1,936

-1,267

3,149

438

20

-120

173

-86

-75

-68

Deposits and other assets

5,819

3,176

5,091

-1,098

10,754

708

-34

111

308

59

22

237

226

124

-16

158

12

52

75

-120

-138

-597

259

695

-17

-14

7

-2

-39

Accounts payable and accrued expenses

-4,000

26,141

8,241

21,107

-28,653

25,271

16,381

9,035

-6,810

12,204

-645

16,375

-3,923

2,179

5,515

-983

-2,452

14,110

8,910

-450

-5,589

12,628

5,152

2,606

-3,472

2,001

146

-1,411

4,446

Other liabilities

1,264

1,115

3,902

586

8,065

315

1,132

960

-475

-74

350

1,081

-624

-1,481

681

24

-23

-23

-23

-23

-23

-12

-22

-23

-23

-22

-265

2

1

Deferred revenue

-1,200

-2,969

-930

1,937

574

581

2,729

1,795

1,409

-1,241

6,106

4,022

582

758

181

344

243

3

44

-373

-2,981

2,585

527

-250

-386

-2,753

-3,593

-5,300

-4,907

Net cash used in operating activities

-81,554

-10,206

-15,502

-30,522

-42,409

-15,143

3,377

3

-15,878

21,288

-15,769

13,320

-28,902

-13,319

-24,075

-24,585

-41,587

-30,332

-27,761

-29,819

-36,425

-7,993

-17,036

-18,807

-13,438

-14,463

-5,176

-19,435

-7,847

Purchases of fixed assets

6,023

4,653

4,253

1,986

2,865

4,608

1,302

708

479

2,043

479

354

225

1,236

265

10

265

956

587

294

883

3,508

319

651

186

372

377

75

21

Purchase of convertible debt security

10,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

298,814

254,682

13,125

60,538

165,723

39,958

0

5,973

22,683

61,901

0

0

19,467

11,685

27,436

26,843

19,413

89,463

89,311

25,880

19,108

115,202

-1

107,249

25,354

-

-

-

-

Sale and redemption of marketable securities

224,997

41,770

56,076

40,334

18,090

24,500

29,984

14,425

21,514

9,902

20,490

100,247

44,110

36,052

65,937

47,850

41,795

38,589

83,614

42,870

40,598

5,525

48,696

31,806

21,273

-

-

-

-

Acquisition of product rights and licenses

11,434

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-101,274

-228,997

30,429

-38,171

-150,498

-24,596

-24,113

7,744

-1,648

-54,042

19,272

23,469

24,418

23,131

38,236

20,997

22,117

-51,830

-6,284

16,696

20,607

-113,185

48,378

-76,094

-4,267

5,867

-122,016

-11,659

-21

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

12

37

35

2,786

1,105

1,069

Net proceeds from sale of Series Four preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

4,327

56,458

Proceeds from exercise of options

9,987

6,081

8,066

2,848

1,281

2,237

5,039

2,456

1,136

745

902

429

106

42

892

0

34

22

617

5,053

3,019

-

-

-

-

-

-

-

-

Proceeds from shares issued under employee stock purchase plan

-

-

-

-

-

-

-

-

-

1,106

805

0

557

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from public offerings

13,503

-506

99,717

104

224,441

1

41

117,874

0

-

-

-

-

-

-

-

-

-

-

-

-

117,596

0

200

118,183

-

-

-

-

Repayment of senior secured term loan

5,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

18,490

2,284

382,354

2,849

225,722

3,726

5,080

121,629

1,136

1,851

1,707

39,997

663

42

892

0

34

22

145,967

5,053

3,019

118,403

359

218

118,146

-35

-2,856

134,942

55,389

Effect of exchange rate changes on cash

-403

1,370

-2,298

794

-1,169

-1,402

-1,219

-3,263

2,273

857

3,617

2,119

-394

-1,819

-425

-919

1,579

-550

-430

465

-124

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-164,741

-235,549

394,983

-65,050

31,646

-37,415

-16,875

126,113

-14,117

-30,046

8,827

78,905

-4,215

8,035

14,628

-4,507

-17,857

-82,690

111,492

-7,605

-12,923

-3,125

31,701

-94,683

100,441

-8,631

-130,049

103,848

47,521

Supplemental disclosure of cash information
Cash paid for interest

4,878

651

3,931

0

3,111

846

3,089

815

3,023

775

3,022

224

2,250

0

2,250

0

2,263

-

-

-

-

0

0

0

1

1

83

120

162

Cash paid for income taxes

507

178

918

476

537

664

161

432

326

485

282

306

28

310

369

39

225

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of non-cash information related to investing and financing activities
Unrealized gain on marketable securities

-63

289

-463

839

59

59

33

40

-123

-

-

-

-

-43

-189

-40

658

380

-483

-224

125

-318

-159

10

10

-

-

-

-

Supplemental disclosure of non-cash investing and financing activity
Right-of-use assets obtained in exchange for lease obligations

22,642

1,269

4,477

329

11,314

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of product rights and licenses

2,775

4,002

-837

8,269

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in carry value of preferred securities resulting from recapitalization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

0

3,391